{"doi":"10.1158/2159-8290.cd-nb2013-170","title":"ICR Expands CanSAR Drug Discovery Platform","abstract":"<jats:title>Abstract</jats:title>\n               <jats:p>The UK's Institute of Cancer Research, London has broadened its CanSAR knowledgebase, a cancer drug–discovery platform that integrates genomic, chemical, and pharmacologic data. The newly released CanSAR 2.0 adds more prediction methodologies and holds data on more than 8 million experimentally derived measurements, nearly 1 million biologically active chemical compounds, and more than 1,000 cancer cell lines.</jats:p>","journal":"Cancer Discovery","year":2014,"id":603827,"datarank":0.10397207708399181,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"self_citation_contribution":0.10397207708399181,"citation_network_contribution":0.0,"self_endowment_contribution":0.10397207708399181,"citer_contribution":0.0,"corpus_percentile":22.1,"corpus_rank":9528,"citation_count":1,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":true,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"ICR Expands CanSAR Drug Discovery Platform","abstract":"<jats:title>Abstract</jats:title>\n               <jats:p>The UK's Institute of Cancer Research, London has broadened its CanSAR knowledgebase, a cancer drug–discovery platform that integrates genomic, chemical, and pharmacologic data. The newly released CanSAR 2.0 adds more prediction methodologies and holds data on more than 8 million experimentally derived measurements, nearly 1 million biologically active chemical compounds, and more than 1,000 cancer cell lines.</jats:p>","is_dataset_classified":null,"base_score":0.6931471805599453,"endowment":0.6931471805599453,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"24402955","pmcid":null,"openalex_id":"https://openalex.org/W4239572564","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.35611429,"influential_citations":0,"citation_trend":[{"year":2018,"count":1}],"oa_status":"closed","license":null,"oa_locations":[{"url":"https://aacrjournals.org/cancerdiscovery/article/4/1/OF3/3923/ICR-Expands-CanSAR-Drug-Discovery-PlatformICR","host_type":"publisher"},{"url":"https://doi.org/10.1158/2159-8290.cd-nb2013-170","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/24402955","host_type":"repository"}],"fields_of_study":["Computational Drug Discovery Methods","Metabolomics and Mass Spectrometry Studies","Machine Learning in Materials Science","Antineoplastic Agents","Databases, Factual","Drug Discovery","Humans","Neoplasms"],"mesh_terms":["Antineoplastic Agents","Humans","Neoplasms","Databases, Factual","Drug Discovery"],"keywords":["Drug discovery","Cancer drugs","Cancer cell lines","Computational biology","Anticancer drug","Drug","Cancer","Cancer cell","Computer science","Data science","Biology","Bioinformatics","Chemistry","Pharmacology","Genetics"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-29T22:48:52.642524Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}